Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SAN-FELIX, A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 17 of 17

  • Page / 1
Export

Selection :

  • and

CYANOSUGARS. II: SYNTHESIS OF HEXOPYRANOSYL CYANIDES BY REACTION OF GLYCALS WITH TRIMETHYLSILYL CYANIDEDE LAS HERAS FG; SAN FELIX A; FERNANDEZ RESA P et al.1983; TETRAHEDRON; ISSN 0040-4020; GBR; DA. 1983; VOL. 39; NO 9; PP. 1617-1620; BIBL. 24 REF.Article

TSAO derivatives, inhibitors of HIV-1 reverse transcriptase dimerization : Recent progress : HIV-1 reverse transcriptase inhibitors: Drug resistance and drug developmentCAMARASA, M. J; VELAZQUEZ, S; SAN-FELIX, A et al.Current pharmaceutical design. 2006, Vol 12, Num 15, pp 1895-1907, issn 1381-6128, 13 p.Article

Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2',5'-Bis-O-(tert-butyldimethylsilyl)β-D-ribofuranosyl]-3-N-methyl-thymine]-3'-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)BALZARINI, J; NAESENS, L; BOHMAN, C et al.Biochemical pharmacology. 1993, Vol 46, Num 1, pp 69-77, issn 0006-2952Article

Synthesis and anti-HIV activity of [AZT]-[TSAO-T] and [AZT]-[HEPT] dimers as potential multifunctional inhibitors of HIV-1 reverse transcriptaseVELAZQUEZ, S; ALVAREZ, R; SAN-FELIX, A et al.Journal of medicinal chemistry (Print). 1995, Vol 38, Num 10, pp 1641-1649, issn 0022-2623Article

Human immunodeficiency virus type 1 (HIV-1) strains selected for resistance against the HIV-1-specific [2',5'-bis-O-(tert-butyldimethylsilyl)-3'-spiro-5″-(4″-amino-1″,2″-oxathiole-2″,2″-dioxide)]-β-D-pentofuranosyl (TSAO) nucleoside analogues retina sensitivity to HIV-1-specific nonnucleoside inhibitorsBALZARINI, J; KARLSSON, A; VELAZQUEZ, S et al.Proceedings of the National Academy of Sciences of the United States of America. 1993, Vol 90, Num 15, pp 6952-6956, issn 0027-8424Article

[2',5'-bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4-amino-1,2-oxathiole-2,2-dioxide) (TSAO) derivatives of purine and pyrimidine nucleosides as potent and selective inhibitors of human immunodeficiency virus type 1BALZARINI, J; PEREZ-PEREZ, M.-J; SAN-FELIX, A et al.Antimicrobial agents and chemotherapy. 1992, Vol 36, Num 5, pp 1073-1080, issn 0066-4804Article

TSAO-T analogues bearing amino acids at position N-3 of thymine: synthesis and anti-human immunodeficiency virus activityCHAMORRO, C; DE CLERCQ, E; BALZARINI, J et al.Antiviral chemistry & chemotherapy. 2000, Vol 11, Num 1, pp 61-69, issn 0956-3202Article

Novel series of TSAO-T derivatives. Synthesis and anti-HIV-1 activity of 4-, 5-, and 6-substituted pyrimidine analoguesSAN-FELIX, A; VELAZQUEZ, S; PEREZ-PEREZ, M. J et al.Journal of medicinal chemistry (Print). 1994, Vol 37, Num 4, pp 453-460, issn 0022-2623Article

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-3'-spiro-5-(4-amino-1,2-oxathiole 2,2-dioxide) (TSAO) analogues : synthesis and anti-HIV-1 activityALVAREZ, R; VELAZQUEZ, S; SAN-FELIX, A et al.Journal of medicinal chemistry (Print). 1994, Vol 37, Num 24, pp 4185-4194, issn 0022-2623Article

Kinetics of inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase by the novel HIV-1-specific nucleoside analogue [2',5'-bis-O-(tert-butyldimethylsilyl)-β-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO-T)BALZARINI, J; PEREZ-PEREZ, M.-J; SAN-FELIX, A et al.The Journal of biological chemistry (Print). 1992, Vol 267, Num 17, pp 11831-11838, issn 0021-9258Article

Cyanosugars. III: The reaction of trimethylsilyl cyanide with keto, epoxy and acetal derivatives of carbohydratesDE LAS HERAS, F. G; SAN FELIX, A; CALVO-MATEO, A et al.Tetrahedron (Oxford. Print). 1985, Vol 41, Num 18, pp 3867-3873, issn 0040-4020Article

An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptaseCHAMORRO, C; CAMARASA, M.-J; PEREZ-PEREZ, M.-J et al.Antiviral chemistry & chemotherapy. 1998, Vol 9, Num 5, pp 413-423, issn 0956-3202Article

Interaction of the antibiotic sparsomycin with the ribosomeLAZARO, E; SAN FELIX, A; VAN DEN BROEK, L. A. G. M et al.Antimicrobial agents and chemotherapy. 1991, Vol 35, Num 1, pp 10-13, issn 0066-4804, 4 p.Article

Chemical, biochemical and genetic endeavours characterizing the interaction of sparsomycin with the ribosomeLAZARO, E; VAN DEN BROEK, L. A. G. M; SAN FELIX, A et al.Biochimie (Paris). 1991, Vol 73, Num 7-8, pp 1137-1143, issn 0300-9084Article

Stereospecific synthesis of branched-chain sugars by a novel aldol-type cyclocondensationPEREZ-PEREZ, M.-J; CAMARASA, M.-J; DIAZ-ORTIZ, A et al.Carbohydrate research. 1991, Vol 216, pp 399-411, issn 0008-6215Article

Diphosphate modified antiviral analogues of uridine 5'-diphosphate glucose derivativesFERNANDEZ-RESA, P; GARCIA-LOPEZ, M.-T; DE LAS HERAS, F. G et al.European journal of medicinal chemistry. 1986, Vol 21, Num 3, pp 245-249, issn 0223-5234Article

A new procedure for the synthesis of glycosyl isothiocyanatesCAMARASA, M. J; FERNANDEZ-RESA, P; GARCIA-LOPEZ, M. T et al.Synthesis (Stuttgart). 1984, Num 6, pp 509-510, issn 0039-7881Article

  • Page / 1